Alaunos Therapeutics, Inc. (TCRT) Financials

TCRT Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2023 19.4 million 5.5 million
June 30, 2023 27.9 million 6.3 million
March 31, 2023 48.6 million 19.1 million
Dec. 31, 2022 64.9 million 26.4 million

TCRT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -6.4 million 726000
June 30, 2023 -7.1 million 914000
March 31, 2023 -9.4 million 910000
Dec. 31, 2022 -7.2 million 877000

TCRT Net Income

No data available :(

TCRT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 11.9 million - 1.2 million
June 30, 2023 18.3 million - 1.6 million
March 31, 2023 23.5 million - 2.6 million
Dec. 31, 2022 39.1 million - 2.7 million

TCRT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 240.0 million
June 30, 2023 239.8 million
March 31, 2023 239.7 million
Dec. 31, 2022 223.4 million

TCRT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 1000 3.7 million 3.6 million -
June 30, 2023 135000 5.2 million 3.0 million -
March 31, 2023 61000 6.5 million 3.2 million -
Dec. 31, 2022 116000 5.6 million 9.7 million -6.8 million

TCRT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 1.1 million
June 30, 2023 4000 1.5 million
March 31, 2023 - 696000
Dec. 31, 2022 11000 805000

TCRT

Price: $2.44

52 week price:
1.67
6.20

Earnings Per Share: -2.30 USD

P/E Ratio: -1.57

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 416200

Market Capitalization: 6.0 million

Links: